Qube Research & Technologies (QRT)’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,697	Closed	-$1.72M	–	1832
2020 Q2	$1.72M	Buy	+8,697	New	+$1.8M	0.03%	702
2020 Q1	–	Sell	-4,138	Closed	-$856K	–	1341
2019 Q4	$856K	Buy	4,138 +2,132	+106%	+$394K	0.03%	680
2019 Q3	$306K	Buy	+2,006	New	+$329K	0.2%	152
2018 Q2	–	Sell	-1,830	Closed	-$182K	–	860
2018 Q1	$182K	Buy	+1,830	New	+$197K	0.07%	176

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LKFT Position: Q3 2020 in Review

Qube Research & Technologies (QRT) sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 8,697 shares — an estimated $1.72M sold.

Qube Research & Technologies (QRT) first reported a position in LKFT in Q1 2018 and held it in 4 quarters. The position peaked at $1.72M in Q2 2020. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

Qube Research & Technologies (QRT) reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 8,697 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $1.72M.
Qube Research & Technologies (QRT) first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and held it in 4 quarters.
Qube Research & Technologies (QRT)'s Lakefront Biotherapeutics American Depositary Shares position peaked at $1.72M in Q2 2020.
119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2020, filed 12 Nov 2020.